[ANCA-vasculitis with renal impairment treated by intravenous versus oral cyclophosphamide: Multicentric analysis of relapse free survival (VaReCyS)].

CONCLUSION: In this retrospective multicentric analysis, oral cyclophosphamide induction was not associated with better relapse free survival after adjustment with age, steroid and maintenance therapy duration. Maintenance therapy duration is believed to better prevent ANCA-vasculitis relapse.
PMID: 32653427 [PubMed - as supplied by publisher]

Source: Nephrologie and Therapeutique - July 7, 2020 Category: Urology & Nephrology Authors: Gouin JB, Dhalluin T, Perrichot R, Vigneau C, Michel A Tags: Nephrol Ther Source Type: research